BRIEF-Medigene Q1 royalties from drug Veregen up 39 pct at 589,000 euros

May 12, 2015 6:14 AM

12 0

* Q1 total revenue fell in reporting period to 1,686 thousand euros ($1.88 million) (Q1 2014: 2,430 thousand euros)

* EBITDA loss rose in Q1 of 2015 to 2,042 thousand euros (Q1 2014: 1,452 thousand euros)

Also read: U.S. life expectancy falls, as many kinds of death increase

Read more

To category page

Loading...